Edition:
India

PDL BioPharma Inc (PDLI.OQ)

PDLI.OQ on NASDAQ Stock Exchange Global Select Market

2.85USD
8 Dec 2017
Change (% chg)

$0.06 (+2.15%)
Prev Close
$2.79
Open
$2.78
Day's High
$2.87
Day's Low
$2.74
Volume
240,127
Avg. Vol
461,467
52-wk High
$3.55
52-wk Low
$1.93

Select another date:

Tue, Nov 14 2017

BRIEF-PDL Biopharma Inc files for non-timely 10-Q

* PDL Biopharma Inc files for non-timely 10-Q - SEC filing‍​ Source text: (http://bit.ly/2AC3Kyu) Further company coverage:

BRIEF-PDL Biopharma urges Neos Therapeutics to provide update on sale process

* PDL Biopharma's proposal to acquire Neos Therapeutics expires today; PDL urges Neos to provide update on sale process

BRIEF-PDL Biopharma Inc reports Q3 revenue $62.7 million

* PDL Biopharma Inc announces third quarter 2017 financial results

Neos Therapeutics to consider other offers after PDL snub: sources

U.S. drugmaker Neos Therapeutics Inc , which this week rejected a fourth takeover offer by PDL Biopharma Inc , will consider offers from other potential buyers, according to people familiar with the matter.

CORRECTED-Neos Therapeutics to consider other offers after PDL snub -sources

Oct 31 U.S. drugmaker Neos Therapeutics Inc , which this week rejected a fourth takeover offer by PDL Biopharma Inc, will consider offers from other potential buyers, according to people familiar with the matter.

BRIEF-PDL Biopharma issues response to Neos Therapeutics rejection of PDL acquisition proposal

* PDL Biopharma issues statement in response to Neos Therapeutics rejection of PDL acquisition proposal

BRIEF-PDL Biopharma announces settlement agreement with Valeant

* PDL Biopharma - ‍Valeant to pay a one-time, lump-sum payment of $13.0 million as part of settlement

BRIEF-Neos Therapeutics‍ confirms it got unsolicited proposal from PDL Biopharma

* Says confirmed it received unsolicited proposal from PDL Biopharma to buy co for $10.25 per share in cash​

BRIEF-PDL BioPharma proposes to acquire Neos Therapeutics for $10.25 per share

* PDL Biopharma proposes to acquire NEOS THERAPEUTICS for $10.25 per share in cash

BRIEF-PDL Biopharma announces new $25 mln share repurchase program

* PDL Biopharma announces new $25 million share repurchase program Source text for Eikon: Further company coverage:

Select another date: